Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena-Alexandra Tataru

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
AMA Journal of Ethics|October 1, 2025
What Matters Ethically About How the UDN Has Changed Since Its Inception?David A Pearce, Elena-Alexandra Tataru
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
Therapeutic Advances in Rare Disease|March 26, 2026
Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews by the IRDiRC telehealth task forceMelissa A Parisi, Adam L Hartman, Mary Catherine V Letinturier, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
AMA Journal of Ethics|October 1, 2025
What Matters Ethically About How the UDN Has Changed Since Its Inception?David A Pearce, Elena-Alexandra Tataru
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
Therapeutic Advances in Rare Disease|March 26, 2026
Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews by the IRDiRC telehealth task forceMelissa A Parisi, Adam L Hartman, Mary Catherine V Letinturier, et al.
Pageof 1